HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

cardiology and are here to stay. Recognizing that they are different from bare metal stents, it is prudent to exercise caution with these devices and avoid using them in patients in whom dual antiplatelet therapy, a common practice used to reduce blood clotting, is unlikely or impossible.

Dr. Peter Fitzgerald of Stanford University Medical Center, who writes with his colleagues, Drs. Shimohama and Honda of the Center for Cardiovascular Technology, offers his view of the future of DESs. While first generation DESs place great emphasis on efficacy, long-term safety issues have arisen, making DESs stand in an exquisite balance among occasionally conflicting effects. Careful reexamination of research findings, as well as redefinition of safe and effective outcomes, will lead future stent technology in the optimal direction.


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2019)... , ... November 15, 2019 , ... ... living with memory impairment, has announced the Best Memory Care Facilities in Amarillo, ... experts, facility features and amenities. , According to the Alzheimer’s Association ...
(Date:11/15/2019)... ... November 15, 2019 , ... PlayCore’s Center ... comprehensive school physical activity programs (CSPAP) on December 3, 2019 at 2 p.m. ... park professionals, this one-hour and 15-minute webinar will discuss the five components of ...
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... cardiologists at Loma Linda University International Heart Institute have performed a ... single access from the axillary artery in the shoulder. The new procedure offers ...
(Date:11/14/2019)... , ... November 14, 2019 , ... ... Drug Administration (FDA) has granted acceptance to file status of its application for ... manifestation in the disease neurofibromatosis type one (NF1). The FDA’s acceptance of the ...
(Date:11/12/2019)... ... November 12, 2019 , ... InteliChart, the ... that Tidewater Physicians Multispecialty Group (TPMG), a network of 220 providers ... patient engagement platform to deliver enhanced patient experience and overall engagement to ...
Breaking Medicine News(10 mins):
(Date:11/14/2019)... ... November 14, 2019 , ... Bioclinica Medical ... that it has reached a milestone in the company’s history: the company has ... submissions from biopharmaceutical clients for therapies and indications subsequently approved by the U.S. ...
(Date:11/14/2019)... NEW YORK (PRWEB) , ... November 14, 2019 ... ... national brand, K-FISH, aimed to promote the quality of Korean seafood and enhance ... two-week-long promotions entitled, "K-Seafood Global Weeks" in many countries. These special events ...
(Date:11/11/2019)... Fla. (PRWEB) , ... November 11, 2019 , ... ... excellence for autologous biologics, is now representing two of the most respected manufacturers in ... Based in Germany, Ameia Med is the leading developer of the ...
Breaking Medicine Technology:
Cached News: